The role of early re-resection in pTaG3 transitional cell carcinoma of the urinary bladder

British Journal of Medical and Surgical Urology

Volumn 4, Issue 4, 2011, Pages 158-165

  Vasdev, Nikhil ^a   McKie, Christopher ^a   Dominguez Escrig, Jose L ^a   El Sherif, Amira ^b   Johnson, Mark I ^a   Durkan, Garrett C ^a   Rix, David A ^a   Thorpe, Andrew C ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

BCG; PTaG3 TCC bladder; Re resection

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER GROWTH; CANCER INCIDENCE; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; CYSTOSCOPY; EARLY INTERVENTION; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; ILEAL CONDUIT; INTRAVENOUS UROGRAPHY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIMARY TUMOR; PRIORITY JOURNAL; RECURRENCE RISK; REOPERATION; RETROSPECTIVE STUDY; RISK REDUCTION; SUPERFICIAL CANCER; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; URINE CYTOLOGY;

EID: 79956082402     PISSN: 18759742     EISSN: 18759750     Source Type: Journal    
DOI: 10.1016/j.bjmsu.2011.01.001     Document Type: Article

References (15)

1. Jakse G., Loidl W., Seeber G. Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavourable tumour?. J Urol 1987, 137:39-43.
2. Stockle M., Alken P., Engelmann U., Jacobi G.H., Riedmiller H., Hohenfellner R. Radical cystectomy - often too late?. Eur Urol 1987, 13:361-367.
3. Silverman D.T., Hartge P., Morrison A.S., Devesa S.S. Epidemiology of bladder cancer. Hematol Oncol Clin North Am 1992, 6(February (1)):1-30.
4. Epstein J.I., Amin M.B., Reuter V.R., Mostofi F.K. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998, 22(December (12)):1435-1448.
5. Jakse G., Algaba F., Malmström P.U., Oosterlinck W. A second-look TUR in T1 transitional cell carcinoma: why?. Eur Urol 2004, 45(May (5)):539-546.
6. Brauers A., Buettner R., Jakse G. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?. J Urol 2001, 165(March (3)):808-810.
7. Brausi M., Collette L., Kurth K., van der Meijden A.P., Oosterlinck W., Witjes J.A., et al. EORTC Genito-Urinary Tract Cancer Collaborative Group. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 2002, 41(May (5)):523-531.
8. Van der Meijden A., Oosterlinck W., Brausi M., Kurth K.H., Sylvester R., de Balincourt C. Significance of bladder biopsies in Ta, T1 bladder tumors: a report of the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder Committee. Eur Urol 1999, 35(April (4)):267-271.
9. Grimm M.O., Steinhoff C., Simon X., Spiegelhalder P., Ackermann R., Vogeli T.A. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 2003, 170(August (2 Pt 1)):433-437.
10. Divrik R.T., Yildirim Ü., Zorlu F., Özen H. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. J Urol 2006, 175(May (5)):1641-1644.
11. Zurkirchen M.A., Sulser T., Gaspert A., Hauri D. Second transurethral resection of superficial transitional cell carcinoma of the bladder: a must even for experienced urologists. Urol Int 2004, 72(2):99-102.
12. Lebret T., Bohin D., Kassardjian Z., Herve J.M., Molinie V., Barre P., et al. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations. J Urol 2000, 163(January (1)):63-67.
13. Herr H.W. Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome. J Urol 2000, 163(January (1)):60-61.
14. Llopis J., Alcaraz A., Ribal M.J., Sole M., Ventura P.J., Barranco M.A., et al. p53 expression predicts progression and poor survival in T1 bladder tumours. Eur Urol 2000, 37:644-653.
15. Babjuk M., Oosterlinck W., Sylvester R., Kaasinen E., Bohle A., Palou-Redorta J. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2008, 54:303-314.